COL2A1 Gene Legg-Calve-Perthes disease Genetic Test
At DNA Labs UAE, we offer the COL2A1 Gene Legg-Calve-Perthes disease Genetic Test at a cost of AED 4400.0. This test is designed to diagnose Legg-Calve-Perthes disease and identify any mutations in the COL2A1 gene that may be associated with the development of the disease.
Test Components and Price
The COL2A1 Gene Legg-Calve-Perthes disease Genetic Test is performed using NGS Technology and the sample condition required is either blood, extracted DNA, or one drop of blood on an FTA Card. The test results will be delivered within 3 to 4 weeks. The test is categorized under Osteology, Dermatology, and Immunology Disorders and is conducted by our expert Dermatologist in the Genetics department.
Pre Test Information
Prior to undergoing the COL2A1 Gene Legg-Calve-Perthes disease Genetic Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected by the disease.
Test Details
The COL2A1 gene is responsible for producing a protein called type II collagen, which is a vital component of connective tissues such as cartilage and the vitreous gel in the eyeball. Mutations in the COL2A1 gene can result in various genetic disorders, including Legg-Calve-Perthes disease.
Legg-Calve-Perthes disease, also known as Perthes disease or avascular necrosis of the femoral head, primarily affects the hip joint in children. It occurs when there is a temporary loss of blood supply to the femoral head, leading to the death of bone cells and subsequent collapse of the femoral head. Symptoms of this condition include pain, limited range of motion, and the development of a limp.
Next-generation sequencing (NGS) genetic testing is utilized to analyze multiple genes simultaneously and identify genetic variations or mutations that may contribute to a specific condition. In the case of Legg-Calve-Perthes disease, NGS genetic testing helps identify mutations in the COL2A1 gene that may be associated with the disease’s development.
By pinpointing specific mutations in the COL2A1 gene through NGS genetic testing, healthcare professionals can offer more accurate diagnoses, predict disease progression, and provide personalized treatment options for individuals with Legg-Calve-Perthes disease.
| Test Name | COL2A1 Gene Legg-Calve-Perthes disease Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for COL2A1 Gene Legg-Calve-Perthes disease NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with COL2A1 Gene Legg-Calve-Perthes disease NGS Genetic DNA Test gene COL2A1 |
| Test Details |
The COL2A1 gene is a gene that provides instructions for making a protein called type II collagen. This protein is a major component of connective tissues such as cartilage and the clear gel that fills the eyeball (vitreous). Mutations in the COL2A1 gene can lead to various genetic disorders, including Legg-Calve-Perthes disease. Legg-Calve-Perthes disease, also known as Perthes disease or avascular necrosis of the femoral head, is a condition that affects the hip joint in children. It occurs when there is a temporary loss of blood supply to the femoral head (the rounded end of the thigh bone that fits into the hip socket), leading to the death of bone cells and subsequent collapse of the femoral head. This can result in pain, limited range of motion, and the development of a limp. Next-generation sequencing (NGS) genetic testing is a method used to analyze multiple genes simultaneously and identify genetic variations or mutations that may be associated with a particular condition. In the context of Legg-Calve-Perthes disease, NGS genetic testing can be used to identify mutations in the COL2A1 gene that may contribute to the development of the disease. By identifying specific mutations in the COL2A1 gene through NGS genetic testing, healthcare professionals can provide more accurate diagnoses, predict disease progression, and offer personalized treatment options for individuals with Legg-Calve-Perthes disease. |
